Perimenopause is the most under-discussed health transition in modern medicine. A generation of women between 40 and 55 has been told their symptoms — disrupted sleep, mood volatility, slow weight gain, brain fog, joint pain, irregular cycles — are "just stress" or "normal aging," and offered very little. The system's reticence has a specific cause: the Women's Health Initiative results in 2002 produced a panic about hormone therapy that took two decades to correct. The 2023 Menopause Society position statement is the formal correction. This piece is about what changed, what the labs actually should look like, and what serious midlife care looks like in 2026.
What changed (the 2023 reset)
The Menopause Society's 2023 position statement formalized what the cardiology and endocrinology literature had been saying for a decade: hormone therapy, in healthy women under 60 and within 10 years of menopause onset, is generally safe for symptom relief, beneficial for bone-loss prevention, and not associated with the cardiovascular harm that the early WHI reads suggested. The earlier panic conflated two populations — younger, recently-menopausal women (where benefits clearly outweigh risks) and older, long-post-menopausal women (where risks rise materially) — into a single warning that scared a generation of physicians off prescribing for either group.
The clinical implication: most women in their 40s and 50s presenting with significant perimenopausal or menopausal symptoms are candidates for evaluation, and many are candidates for therapy. The conversation should be about the specific risk-benefit picture for the individual patient, not a categorical refusal.
The labs that actually matter
A complete perimenopause workup at Wellness Elite Fitness includes:
- Sex hormones: estradiol, FSH, LH, progesterone (timed to cycle days 19–21 if still cycling), free and total testosterone, SHBG, DHEA-S
- Thyroid: TSH, free T3, free T4, reverse T3, anti-TPO antibodies (skip the TSH-only screen — it misses meaningful subclinical disease)
- Metabolic: fasting insulin, HbA1c, fasting glucose
- Cardiovascular: ApoB, lipid panel, blood pressure trend
- Bone health: vitamin D 25-OH, calcium, alkaline phosphatase, baseline DEXA bone density
- Iron: ferritin, iron, TIBC — heavy perimenopausal cycles often produce iron deficiency that masquerades as fatigue
- General: CMP, CBC, CRP
A symptom intake matters as much as the labs. The two highest-leverage questions for triage: how disrupted is sleep, and how disrupted is mood. Numbers contextualize the symptoms; they don't replace them.
Treatment options worth knowing
Hormone therapy (HT): for vasomotor symptoms, sleep disruption, mood, bone protection. Estradiol (transdermal preferred for cardiovascular safety profile) plus progesterone if uterus is intact. Dosing is conservative and titrated to symptoms.
Lifestyle as foundation: resistance training (preserves muscle and bone), Zone 2 cardio (metabolic and mood), sleep hygiene (the single biggest lever for most perimenopausal women), protein intake (1.6–2.0 g/kg body weight), creatine monohydrate (5g/day, evidence-supported in women over 40 for muscle and cognitive function).
Targeted nutrition: magnesium glycinate for sleep and mood, vitamin D where deficient, omega-3s, careful evaluation of iron if cycles are heavy.
Non-hormonal options for women who can't or won't use HT: SSRIs/SNRIs for vasomotor symptoms, fezolinetant (the new NK3 receptor antagonist), gabapentin, cognitive behavioral therapy for hot flashes (yes, this works).
FAQ
What changed about hormone therapy in 2023?
The Menopause Society's 2023 position statement formalized the evidence-based return of HT after the WHI overcorrection. Healthy women under 60, within 10 years of menopause, with no contraindications can use HT safely for symptom relief and bone protection.
What labs should I ask for in perimenopause?
Estradiol, FSH, LH, progesterone (cycle days 19–21), free/total testosterone, SHBG, DHEA-S, full thyroid (TSH, fT3, fT4), vitamin D, ferritin, fasting insulin, HbA1c, ApoB. Plus a symptom intake — sleep and mood disruption are the two highest-leverage questions.
When does perimenopause start?
Most commonly 40–47, sometimes earlier. Transition lasts 4–8 years before menopause (average age 51). Symptoms often peak 1–2 years before and after the final cycle.
Where can women get hormone evaluation in Houston?
Elite Aesthetic MD, the independent medical practice of Dr. Swet Chaudhari, MD, located inside Wellness Elite Fitness, offers full panels and physician-supervised midlife hormone care for members who opt in. Book a private tour.
—